DCF — NORTH OKALOOSA MEDICAL CENTER
Enterprise Value: $76.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$76.5M
Enterprise Value
$19.5M
PV of Cash Flows
$57.0M
PV of Terminal Value
$91.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $123.6M | $10.5M | 9.0% | $3.4M | $3.1M |
| Year 2 | $127.3M | $12.1M | 10.0% | $4.5M | $3.7M |
| Year 3 | $131.1M | $13.8M | 11.0% | $5.6M | $4.2M |
| Year 4 | $135.1M | $14.9M | 11.0% | $6.3M | $4.3M |
| Year 5 | $139.1M | $15.7M | 11.0% | $6.7M | $4.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $76.5M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$120.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000299972546
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5